CD36 participates in tumor maintenance through its expression in intratumoral Treg cells by CD36-dependent metabolic adaptation (Wang et al., 2020) and also participates in inflammation and sterile inflammation via TLR 4 and 6 activations (Stewart et al., 2010; Xu et al., 2018). The gene discussed is CD36; the disease is neoplasm.